Roche Immunomics - human
- Version
- v1.0
- Date of creation of the dataset
- -
- Date of the last update of the dataset
- -
- Experiment types
- transcriptomics
- Type of Samples Collected
- blood
- Number of Samples Collected
- 339
- Treatment or experiment categories
- Illumina full length RNA sequencing
- Data owner
- Roche Pharma Research & Early Development (pRED)
- Main contact
- -
- -
- Affiliation
- -
| FAIR maturity level | Pre-FAIRification Assessment | Post-FAIRification Assessment |
| Overall | 0.0 | 0.0 |
| Representation & Format | 0.67 | 1.0 |
| Content | 0.25 | 0.75 |
| Hosting | 0.5 | 0.75 |
| FAIR maturity indicators | FAIR Dataset Maturity (DSM) Model v1.0 | |
hardware Obligations
| Note | Category Note | GA4GH label | GA4GH code |
|---|---|---|---|
| The requestor must agree to collaboration with the primary study investigator(s). | Collaboration required | COL | |
| The requestor must provide documentation of local IRB/ERB approval. | Ethics approval required | IRB | |
| The requestor agrees not to publish results of studies until a specific date. | Publication moratorium | MOR | |
| The requestor must return derived or enriched data to the resource. | Return to database or resource | RTN |
info Constrained permissions
| Note | Category Note | GA4GH label | GA4GH code |
|---|---|---|---|
| Use is limited to within an approved institution | Institution specific restriction | IS | |
| Use is limited to within an approved project | Project specific restriction | PS | |
| Use is approved for a specific number of months | Time limit on use | TS | |
| Use is limited to approved users | User specific restriction | US |
